Daniel J. Wallace

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

Michelle Petri, Ana‐Maria Orbai, Graciela S. Alarcón et al. · Arthritis & Rheumatism · 2012 · 5.3K citations · Full text

Life Sciences, Immunology, Clinical Classification Systems +11

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Martin Aringer, Karen H. Costenbader, David Daikh et al. · Arthritis & Rheumatology · 2019 · 2.5K citations · Full text

Life Sciences, Immunology, Internal Medicine +17

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Richard Furie, Michelle Petri, Omid Zamani et al. · Arthritis & Rheumatism · 2011 · 1.7K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

Bevra H. Hahn, Maureen McMahon, Alan Wilkinson et al. · Arthritis Care & Research · 2012 · 1.5K citations

Medicine, Immunology, Nephrology +15

Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

Joan T. Merrill, C. Michael Neuwelt, Daniel J. Wallace et al. · Arthritis & Rheumatism · 2009 · 1.4K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +13